WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD
121.59
+1.49 (+1.24%)
At close: 4:06PM EDT
Stock chart is not supported by your current browser
Previous Close120.10
Open120.03
Bid0.00 x 800
Ask0.00 x 1300
Day's Range120.03 - 121.99
52 Week Range82.74 - 122.00
Volume503,262
Avg. Volume354,533
Market Cap8.942B
Beta1.26
PE Ratio (TTM)60.86
EPS (TTM)2.00
Earnings DateOct 24, 2018 - Oct 29, 2018
Forward Dividend & Yield0.56 (0.46%)
Ex-Dividend Date2018-07-17
1y Target Est104.43
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
    Markit19 days ago

    See what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.

    West Pharmaceutical Services Inc NYSE:WST

  • Is West Pharmaceutical Services Inc’s (NYSE:WST) PE Ratio A Signal To Sell For Investors?
    Simply Wall St.23 days ago

    Is West Pharmaceutical Services Inc’s (NYSE:WST) PE Ratio A Signal To Sell For Investors?

    I am writing today to help inform people who are new to the stock market and want to begin learning about how to value company based on its current earningsRead More...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of WST earnings conference call or presentation 26-Jul-18 1:00pm GMT

    Q2 2018 West Pharmaceutical Services Inc Earnings Call

  • Associated Press2 months ago

    West Pharmaceutical: 2Q Earnings Snapshot

    The Exton, Pennsylvania-based company said it had profit of 75 cents per share. Earnings, adjusted for pretax gains, were 70 cents per share. The results surpassed Wall Street expectations. The average ...

  • PR Newswire2 months ago

    West Announces Second-Quarter 2018 Results

    - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter ...

  • West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
    PR Newswire2 months ago

    West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering

    EXTON, Pa., July 19, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced manufacturing network, and the launch of a new product line—Westar® Select. Customers and senior-level Irish government officials joined West at a ribbon-cutting ceremony to celebrate the facility's opening and to recognize West's ongoing commitment to improving patient lives through their products and services. "West is very pleased to celebrate the official opening of our state-of-the-art facility in Waterford, as well as the launch of Westar Select, both of which are the culmination of efforts by many to support our company's commitment to meeting the dynamic needs of our pharmaceutical and biotech partners," said Eric Green, President and CEO, West.

  • CNBC2 months ago

    Cramer's lightning round: Cigna's stock is undervalued considering its latest acquisition

    It's that time again! "Mad Money" host Jim Cramer rang the lightning round bell, which means he gave his take on callers' favorite stocks at rapid speed. Cigna Corporation CI : “OK, when [CEO] David Cordani came on, the stock was right around here. Sociedad Quimica y Minera de Chile S.A SQM-X.A-CL .: “Sociedad Quimica is not an expensive stock if lithium takes off.

  • West to Host Second-Quarter 2018 Conference Call
    PR Newswire2 months ago

    West to Host Second-Quarter 2018 Conference Call

    EXTON, Pa. , July 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release ...

  • Why Wistil Spólka Akcyjna (WSE:WST) Should Have A Place In Your Portfolio
    Simply Wall St.3 months ago

    Why Wistil Spólka Akcyjna (WSE:WST) Should Have A Place In Your Portfolio

    Wistil Spólka Akcyjna (WSE:WST) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In theRead More...

  • West Pharmaceutical Services Inc (NYSE:WST): Should The Recent Earnings Drop Worry You?
    Simply Wall St.3 months ago

    West Pharmaceutical Services Inc (NYSE:WST): Should The Recent Earnings Drop Worry You?

    Examining West Pharmaceutical Services Inc’s (NYSE:WST) past track record of performance is a valuable exercise for investors. It enables us to understand whether the company has met or exceed expectations,Read More...

  • West Appoints Bernard Birkett to Chief Financial Officer
    PR Newswire3 months ago

    West Appoints Bernard Birkett to Chief Financial Officer

    EXTON, Pa., June 21, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer and Treasurer, effective June 21, 2018. Mr. Birkett will succeed William J. Federici, who announced in March his intention to retire later this year. Mr. Birkett joins West from Merit Medical Systems, Inc., a leading manufacturer of disposable medical devices, where he most recently served as Chief Financial Officer and Treasurer.

  • PR Newswire3 months ago

    West's SelfDose™ Patient-Controlled Injector Wins Silver Medical Design Excellence Award

    EXTON, Pa., June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Delivery and Combination Products" for its SelfDose™ Patient-Controlled Injector. The honor was presented to West and its customer Accord Healthcare Limited, which uses the SelfDose patient-controlled injector technology with its Methofill™ (methotrexate) SELF INJECT, on June 12, 2018 at the MD&M East Conference in New York City. Organized by Medical Device and Diagnostic Industry magazine, the annual Medical Design Excellence Awards (MDEA) competition recognizes significant achievements in medical product design and engineering and the many people behind the scenes—engineers, scientists, designers and clinicians—who are responsible for the cutting-edge products that are improving patient healthcare.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of WST earnings conference call or presentation 26-Apr-18 1:00pm GMT

    Q1 2018 West Pharmaceutical Services Inc Earnings Call

  • ACCESSWIRE3 months ago

    Complimentary Technical Snapshots on TransEnterix and Three More Medical Supplies Stocks

    LONDON, UK / ACCESSWIRE / June 11, 2018 / If you want a free Stock Review on TRXC sign up now at www.wallstequities.com/registration. Today's attention is redirected to the Medical Instruments and Supplies space, which comprises companies that manufacture and sell medical devices, instrument systems, and reagents and consumables.

  • PR Newswire4 months ago

    West Announces Participation in Upcoming June Investor Conferences

    EXTON, Pa. , May 24, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management ...

  • PR Newswire5 months ago

    West Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences

    EXTON, Pa., May 3, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.  The dividend will be paid on August 1, 2018, to shareholders of record as of July 18, 2018. In addition, the Board of Directors has approved a fourth-quarter dividend of $0.15 per share, a 7.1% increase over the $0.14 per share declared for each of the four preceding quarters.  This is the twenty-sixth consecutive annual increase in the Company's dividend.  The fourth-quarter dividend will be paid on November 7, 2018, to shareholders of record as of October 24, 2018.

  • ACCESSWIRE5 months ago

    West Pharmaceutical Services, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / April 26, 2018 / West Pharmaceutical Services, Inc. (NYSE: WST ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 26, 2018 at 9:00 AM ...

  • Associated Press5 months ago

    West Pharmaceutical: 1Q Earnings Snapshot

    The Exton, Pennsylvania-based company said it had net income of 58 cents per share. Earnings, adjusted for restructuring costs and pretax expenses, were 62 cents per share. The results missed Wall Street ...

  • West Announces First-Quarter 2018 Results
    PR Newswire5 months ago

    West Announces First-Quarter 2018 Results

    - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter ...

  • ACCESSWIRE5 months ago

    EX-Dividend Schedule: Has Raised Dividend for 25 Consecutive Years; Will Trade Ex-Dividend on April 17, 2018

    LONDON, UK / ACCESSWIRE / April 16, 2018 / Active-Investors has a free review on West Pharmaceutical Services, Inc. (NYSE: WST ) following the Company's announcement that it will begin trading ex-dividend ...

  • West to Host First-Quarter 2018 Conference Call
    PR Newswire5 months ago

    West to Host First-Quarter 2018 Conference Call

    EXTON, Pa., April 12, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 9889627.

  • See what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.
    Markit5 months ago

    See what the IHS Markit Score report has to say about West Pharmaceutical Services Inc.

    West Pharmaceutical Services Inc NYSE:WST

  • West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting
    PR Newswire6 months ago

    West to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting

    West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – ...